Um die Funktion von Proteinen in ihrer natürlichen Umgebung zu verstehen, ist es unerlässlich ihre Lokalisation und Bewegung im lebenden System durch z.B Fluoreszenz-markierung sichtbar zu machen. Eine ideale Markierungsmethode zeichnet sich dadurch aus, dass sie das Zielprotein (protein of interest, POI) selektiv und in kurzer Zeit mit einer maßgeschneiderten Reportergruppe ausstattet, ohne die Proteinfunktion und -lokalisation zu beeinflussen. Dabei ist die Größe der Erkennungssequenz von großer Bedeutung. In dieser Arbeit wird die Entwicklung einer Markierungsstrategie beschrieben, bei der die Ausbildung eines parallelen Coiled-Coil-Motivs den Transfer einer Reportergruppe auslöst. Untersucht wurde dabei die Übertragung eines Sulfonat-gebundenen Fluorophors auf ein Cystein in der Erkennungssequenz durch nukleophile Substitution. Ebenfalls untersucht wurde der Transfer verschiedener Thioester-verknüpfter Reporter auf ein N-terminales Cystein der Erkennungssequenz durch eine Acyltransferreaktion. Beide Strategien zeichnen sich durch eine hohe Selektivität und einen geringen Massenzuwachs am Zielprotein aus. Der Acyltransfer mit Arylthioestern zeigte zudem eine bemerkenswerte Reaktivität und erlaubte eine Markierung innerhalb weniger Minuten Reaktionszeit. Die Vielfältigkeit dieser Methode wurde anhand der Fluoreszenzmarkierung von sieben verschiedenen G-Protein gekoppelten Membranrezeptoren auf der Oberfläche lebender Zellen demonstriert. Die markierten Rezeptoren blieben dabei funktional und konnten ihren entsprechenden Liganden mit hoher Affinität binden. / In order to understand the function of proteins in their native environment, it is crucial to visualize their localization and trafficking in living cells by means of e.g. fluorescence labeling. An ideal labeling method adds a custom reporter group to the protein of interest (POI) in a selective and fast manner without disturbing the POIs function and localization. Hence the size of the recognition sequence is of major concern. This work describes the development of a labeling strategy in which the formation of a parallel coiled coil motif triggers the transfer of a reporter group. The transfer of a sulfonate-linked fluorescence dye onto the cysteine-modified recognition sequence via a nucleophilic substitution reaction was tested. Also the transfer of various thioester-linked reporters onto the N-terminal cysteine of the recognition sequence via an acyl transfer reaction was investigated. Both strategies are characterized by a high selectivity and low mass increase at the target protein. The acyl transfer with aryl thioesters also showed a remarkable reactivity and allowed labeling reactions to proceed within minutes. The versatility of this method was demonstrated by applying it to the labeling of seven different G-protein coupled membrane receptors on the surface of living cells. The labeled receptors remained functional and were able to bind their respective ligand with high affinity.

Nukleinsäuren und Peptide erlauben es, Kontrolle über molekulare Prozesse auszuüben. In dieser Arbeit werden strukturgebende Elemente wie Coiled-Coil-Peptide oder PNA∙DNA-Strukturen genutzt, um Rezeptoren auf lebenden Zellen zu markieren und in ihrem Verhalten zu modulieren, oder cytosolische Proteine in ihrem Bindungsverhalten zu steuern. Im ersten Konzept wird die Interaktion des Coiled-Coil-Paars K3/E3 genutzt, um eine Transferreaktion, in welcher eine PNA-Sequenz vom K3-Donor auf den E3-Akzeptor übertragen wird, zu induzieren. Durch die Fusion des Akzeptorpeptids mit einem Rezeptor werden kovalente PNA-Rezeptorkonjugate auf der Oberfläche lebender Zellen geschaffen. Die Reaktion zwischen Thiol und Thioester erlaubt dabei einen schnellen Transfer. So wurden Rezeptoren aus der Familie der GPCR sowie der EGFR mit einem PNA-Strang versehen und durch fluoreszente PNA oder DNA selektiv markiert. Zusätzlich wurden verzweigte DNA-Architekturen mit mehreren Fluorophoren genutzt, um die Helligkeit der Markierung quantitativ zu erhöhen. Die PNA-EGFR-Konjugate wurden durch eine zwei Rezeptoren verbrückende Cy3-DNA adressiert und so zeitgleich markiert und dimerisiert. Dadurch wurde die Rezeptoraktivität gesteigert, was über Western Blot-, Immunofluoreszenz- und Fluoreszenzmikroskopieanalyse belegt wurde. In weiteren Ansätzen wurden Coiled-Coil-Systeme genutzt, um i) parallel zwei verschiedene Akzeptorpeptide mit verschiedenen Fluorophoren zu markieren und ii) Coiled-Coil-Peptide schaltbar zu machen. Durch die asymmetrische Verlängerung von K3/E3-Paaren mit Coiled-Coil-Sequenzen kann die Interaktion der Peptide an und aus geschaltet werden. Dies wurde sowohl in einem Fluoreszenzassay als auch in einer direkten Anwendung an der Syk-Kinase demonstriert. Die Liganden der Kinase wurden an den schaltbaren Peptiden angebracht und so die Affinität zur Syk-Kinase kontrolliert. / Nucleic acids and peptides can be used to obtain control over molecular processes within living cells. In this work, structural elements as coiled-coil peptides or PNA∙DNA-structures were used to label and modulate receptor behavior on living cells and to control ligand binding of cytosolic proteins. For the first concept the K3/E3-coiled-coil peptide pair was used to establish a proximity-guided, covalent transfer of a PNA strand from a K3-donor peptide onto the complementary E3-acceptor peptide. By fusion of the acceptor peptide to a receptor, PNA-receptor-conjugates were generated selectively on living cells. The native chemical ligation type of reaction allowed a fast PNA-transfer within minutes. Receptors from the family of GPCRs and the EGFR were tagged with a PNA-sequence and subsequently labeled by the addition of a fluorescent DNA or PNA. By recruiting branched DNA architectures which were decorated with several fluorophores, the total brightness of the labeling was increased quantitatively. A twice complementary Cy3-DNA was used to simultaneously label and dimerize the EGFR. Thereby, an artificially induced increase in receptor activity could be achieved, which was shown in Western Blot and immunofluorescence analysis as well as in fluorescence microscopy. In two other approaches coiled-coil peptides were used to i) label two different acceptor peptides simultaneously with two different dyes and ii) introduce coiled-coil peptides as part of a dynamic switchable system. Using an asymmetric coiled-coil elongation on the K3/E3 pair the interaction of both can be turned on and off. This was demonstrated in a fluorescence assay and applied to the Syk kinase, were Syk ligands were attached to the switchable peptides. Those ligands were changed from a bi- to a monovalent presentation status and thus the affinity of the Syk kinase towards its ligands can be controlled.

La polykystose rénale autosomique dominante (PKRAD) est la maladie génétique rénale la plus commune touchant 1/500 personnes. Elle se caractérise principalement par la formation de kystes rénaux dans tous les segments du néphron, entraînant l’insuffisance rénale, et par des manifestations extrarénales kystiques (foie, pancréas, rate) et non-kystiques (anomalies cardiaques, vasculaires et cérébrales). Deux gènes, PKD1 et PKD2, sont responsables de 85 et 15% des cas respectivement. Ces gènes encodent les polycystine-1 (PC-1) et -2 (PC-2) qui forment un complexe à la membrane plasmique et ciliaire des cellules épithéliales rénales. PC-1 est une protéine transmembranaire de 4302 acides aminés possédant un court domaine intracellulaire incluant un motif coiled-coil impliqué dans l’interaction entre PC-1 et PC-2 in-vitro. L’importance du coiled-coil est démontrée par des mutations affectant spécifiquement ce motif chez des patients PKRAD. Le mécanisme pathogénétique responsable de la PKRAD est indéterminé. Chez la souris, la PKRAD se développe suite à l’ablation (Pkd1-/-) ou lors de la surexpression (SBPkd1TAG) de Pkd1, ce qui suggère un effet de dosage. Des anomalies ciliaires sont aussi souvent associées à PKRAD. Mon objectif était de déterminer in-vivo le mécanisme pathogénétique de la polycystine-1 dans le développement des symptômes PKRAD rénaux et extrarénaux et plus spécifiquement, le rôle du motif coiled-coil dans le mécanisme de kystogenèse. Pour ce faire, nous avons généré deux constructions, Pkd1 sauvage (Pkd1TAG) et Pkd1 tronquée de son motif coiled-coil (Pkd1ΔCoiled-coil), par recombinaison homologue à partir du BAC-Pkd1 sauvage comprenant la séquence murine entière de Pkd1. Trois lignées de souris Pkd1TAG générées par microinjection démontrent un niveau d’expression de Pkd1 qui corrèle avec le nombre de copie du transgène (2, 5 et 15 copies). Les souris Pkd1TAG reproduisent la PKRAD en développant des kystes rénaux dans toutes les parties du néphron et des cils primaires plus longs que les contrôles non transgéniques. Les analyses physiologiques supportent que les souris Pkd1TAG développent une insuffisance rénale et démontrent une augmentation du volume urinaire de même qu’une diminution de l’osmolalité, de la créatinine et des protéines urinaires. De plus, les souris Pkd1TAG développent des kystes hépatiques, des anomalies cardiaques associées à des dépôts de calcium et des anévrismes cérébraux. La sévérité du phénotype augmente avec l’expression de Pkd1 appuyant l’hypothèse d’un mécanisme de dosage. Nous avons aussi déterminé que l’expression du transgène Pkd1TAG complémente le phénotype létal-embryonnaire des souris Pkd1-/-. D’autre part, nous avons générés 4 lignées de souris Pkd1ΔCoiled-coil (2 et 15 copies du transgène) dont le nombre de copies corrèle avec le niveau d’expression du transgène. Ces souris Pkd1ΔCoiled-coil, contrairement aux Pkd1TAG de même âge, ne développent pas de kystes et possèdent des cils primaires de longueur normale. Afin d’évaluer le rôle du motif coiled-coil en absence de polycystine-1 endogène, nous avons croisé les souris Pkd1ΔCoiled-coil avec les souris Pkd1-/-. Contrairement aux souris Pkd1-/- qui meurent in-utéro, les souris Pkd1ΔCoiled-coil; Pkd1-/- survivent ~10 à 14 jours après la naissance. Elles démontrent des kystes rénaux et pancréatiques sévères, un retard de croissance et des anomalies pulmonaires. Tous les segments du néphron sont affectés. Mon projet démontre que la surexpression de Pkd1 est un mécanisme pathogénique de la PKRAD tant au niveau rénal qu’extrarénal. De plus, il démontre que le motif coiled-coil est un élément déterminant dans la kystogenèse/PKRAD in-vivo. / Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder affecting 1:500 people worldwide, independently from sex and origin. ADPKD is characterized by formation of large bilateral kidney cysts affecting all segments of the nephron and increasing progressively in size and number leading to end stage renal failure by mid-fifty. Moreover, this systemic disease includes several extrarenal symptoms such as intracranial aneurysms, valvular defects and cysts formation in the liver and the pancreas. PKD1 and PKD2 genes mutations are involved in 85 and 15 % of the clinical cases. PKD genes encode polycystin-1 (PC-1) and -2 (PC-2), which both form a complex at the cell and ciliary membrane of renal epithelial cells. PC-1 is a large transmembrane protein with a small intracellular tail including a coiled-coil motif implicated in PC-1/PC-2 interaction in-vitro. Interestingly, specific mutations affecting the coiled-coil motif cause ADPKD in humans. The pathogenetic mechanism of ADPKD is unknown. In mice, both ablation (Pkd1-/-) or overexpression (SBPkd1TAG) of Pkd1 cause ADPKD, suggesting a dosage model. Ciliary anomalies are also linked to polycystic kidney disease. Herein, we evaluated in-vivo the role of Pkd1 in the development of renal and extrarenal manifestations of ADPKD and more specifically, the role of the coiled-coil motif in cystogenesis. We generated two constructions, wildtype Pkd1 (Pkd1TAG) and coiled-coil deleted Pkd1 (Pkd1ΔCoiled-coil), by homologous recombination from the wildtype Pkd1-BAC comprising the whole Pkd1 murine sequence. Three Pkd1TAG mice lines have been generated by microinjection and show expression patterns correlating with the copy number of the transgene (2, 5 and 15 copy). All Pkd1TAG mice develop renal cysts affecting all nephron segments as in ADPKD and longer primary cilia compared to wildtype mice. Physiologic analysis supports renal failure by increased urinary output and decreased of urinary proteins, osmolality and creatinin levels. Pkd1TAG mice also show cysts in the liver, cardiac and valvular anomalies associated with calcium deposition and cerebral aneurysms. The severity of the phenotype increased with Pkd1 expression suggesting a dosage model. Importantly, the Pkd1TAG transgene rescue embryonic lethality of Pkd1-/- mice. Furthermore, we generated 4 lines of Pkd1ΔCoiled-coil mice of 2 and 15 copies of the transgene correlating also to the level of expression. Compared to age-matched Pkd1TAG, Pkd1ΔCoiled-coil mice develop no cysts and show normal cilia length. To gain more insights on the role of coiled-coil motif in absence of endogenous Pc-1, we mated Pkd1ΔCoiled-coil with Pkd1-/- mice. Compared to the lethal embryonic Pkd1-/- mice, Pkd1ΔCoiled-coil; Pkd1-/- live ~ 10 to 14 days. They show severe renal and pancreatic cysts as well as growth retardation and pulmonary defects. My study demonstrates that Pkd1 overexpression is a pathogenic mechanism to induce ADPKD renal and extrarenal phenotype. Moreover, this work shows that the coiled-coil motif of polycystin-1 is a critical determinant in ADPKD cystogenesis.

Type III secretion systems (T3SS) are a common feature of Gram-negative bacteria, allowing them to inject anti-host effectors into the interior of infected eukaryotic cells. By this mechanism, these virulence factors help the bacteria to modulate eukaryotic cell function in its favor and subvert host innate immunity. This promotes a less hostile environment in which infecting bacteria can colonize and cause disease. In pathogenic Yersinia, a crucial protein in this process is YopD. YopD is a T3S substrate that, together with YopB, forms a translocon pore in the host cell membrane through which the Yop effectors may gain access to the target-cell cytosol. The assembly of the translocator pore in plasma membranes is considered a fundamental feature of all T3SSs. How the pore is formed, what determines the correct size and ultimately the stoichiometry between YopD YopB, is still unknown. Portions of YopD are also observed inside HeLa cells. Moreover, YopD functions together with its T3S chaperone, LcrH, to control Yops synthesis in the bacterial cytoplasm. The multifunctional YopD may influence all these processes by compartmentalizing activities into discrete modular domains along the protein length. Therefore, understanding how particular domains and/or residues within these regions coordinate multiple functions of the protein will provide a platform to improve our knowledge of the molecular mechanisms behind translocation through T3SSs. Comprehensive site-directed mutagenesis of the YopD C-terminal amphipathic α-helix domain, pinpointed hydrophobic residues as important for YopD function. Some YopD variants were defective in self-assembly and in the ability to interact with the needle tip protein, LcrV, which were required to facilitate bacterial T3S activity. A similar mutagenesis approach was used to understand the role of the two predicted coiled-coils located at the N-terminal and C-terminal region of YopD. The predicted N-terminal element that occurs solely in the Yersinia YopD translocator family is essential for optimal T3SS and full disease progression. The predicted YopD C-terminal coiled-coil shapes a functional translocon inserted into host cell membranes. This translocon was seen to be a dynamic structure facilitating at least two roles during effectors delivery into cells; one to guarantee translocon pore insertion into target cell membranes and the other to promote targeted activity of internalized effector toxins. In Yersinia expression of yop genes and secretion of the corresponding polypeptides is tightly regulated at a transcriptional and post-transcriptional level. If T3S chaperones of the translocator class are known to influence transcriptional output of T3SS genes in other bacteria, we show that in Yersinia the class II T3S chaperone LcrH has no such effect on the LcrF transcriptional activator activity. We also demonstrate that there are possibly additional yop-regulatory roles for the LcrH chaperone besides forming a stable complex with YopD to impose post-transcriptional silencing on Yops synthesis. This mechanism that relies upon an active T3SS, might act independently of both YopD and the regulatory element LcrQ. In conclusion, this work has sought to delineate the encrypted functions of the YopD translocator that contribute to Yersinia T3SS-dependent pathogenesis. Contributions of the YopD cognate chaperone LcrH in yop regulatory control are also presented.

Multivalent interactions are common in nature, such as influenza virus infecting epithelial cells, clearance of pathogens by antibody-mediated attachment to macrophages, etc. To mimic nature, we utilized a bottom-up approach to develop various multivalent self-assembling systems based on leucine-zipper peptides. We tethered several pairs of leucine-zipper peptides to PAMAM dendrimers to form leucine-zipper dendrimers (LZDs). We conjugated Fos/Jun to the dendrimer to make D0Fos4 and D0Jun4, and studied the interactions between these LZDs and their cognate peptide target, either Jun or Fos. Our experiments showed that the D0Fos4 can non-covalently assemble four copies of Jun, and this approach can be further used for the rapid non-covalently assembling of multimeric ligands. We also pursued the multivalent target of GPCRs with a Fos/Jun assembly, and found the complex can potentially be used as a molecular switch to target GPCRs with controlled ligand activity. In a related project for bio-material design based on self-assembly of LZDs, we synthesized a different pair of LZDs, D-Ez4 and D-Kz4, and established that they can assemble at neutral pH to form helical fibrils which display higher order self-organized structures, providing a new methodology for bio-material design. In another effort for studying multivalent interactions, we conjugated three copies of the F23, mini-protein that binds the HIV-1 capsid protein, to a trimesic acid and obtained a trivalent inhibitor, Tri-F23. Tri-F23 showed enhanced binding in ELISA against gp120, but was not significantly more effective preventing HIV entry. This methodology provides a new strategy for developing multivalent inhibitors for preventing HIV-1 infection at the entry level. In a related area, we are developing imaging agents based on quantum dots that can detect GPCRs on whole cells and at the single molecule level. To this end, a new method was developed for biocompatible amphphilic polymers to coat quantum dots. This amphiphilic polymer facilitates rapid quantum dot conjugation to any ligand with a free thiol or engineered cysteine. Several GPCR targeted peptides have been utilized for imaging receptors on whole cells and as single molecules. These efforts will guide the rational design of multivalent ligands for targeting GPCRs and other cell surface proteins.

La polykystose rénale autosomique dominante (PKRAD) est la maladie génétique rénale la plus commune touchant 1/500 personnes. Elle se caractérise principalement par la formation de kystes rénaux dans tous les segments du néphron, entraînant l’insuffisance rénale, et par des manifestations extrarénales kystiques (foie, pancréas, rate) et non-kystiques (anomalies cardiaques, vasculaires et cérébrales). Deux gènes, PKD1 et PKD2, sont responsables de 85 et 15% des cas respectivement. Ces gènes encodent les polycystine-1 (PC-1) et -2 (PC-2) qui forment un complexe à la membrane plasmique et ciliaire des cellules épithéliales rénales. PC-1 est une protéine transmembranaire de 4302 acides aminés possédant un court domaine intracellulaire incluant un motif coiled-coil impliqué dans l’interaction entre PC-1 et PC-2 in-vitro. L’importance du coiled-coil est démontrée par des mutations affectant spécifiquement ce motif chez des patients PKRAD. Le mécanisme pathogénétique responsable de la PKRAD est indéterminé. Chez la souris, la PKRAD se développe suite à l’ablation (Pkd1-/-) ou lors de la surexpression (SBPkd1TAG) de Pkd1, ce qui suggère un effet de dosage. Des anomalies ciliaires sont aussi souvent associées à PKRAD. Mon objectif était de déterminer in-vivo le mécanisme pathogénétique de la polycystine-1 dans le développement des symptômes PKRAD rénaux et extrarénaux et plus spécifiquement, le rôle du motif coiled-coil dans le mécanisme de kystogenèse. Pour ce faire, nous avons généré deux constructions, Pkd1 sauvage (Pkd1TAG) et Pkd1 tronquée de son motif coiled-coil (Pkd1ΔCoiled-coil), par recombinaison homologue à partir du BAC-Pkd1 sauvage comprenant la séquence murine entière de Pkd1. Trois lignées de souris Pkd1TAG générées par microinjection démontrent un niveau d’expression de Pkd1 qui corrèle avec le nombre de copie du transgène (2, 5 et 15 copies). Les souris Pkd1TAG reproduisent la PKRAD en développant des kystes rénaux dans toutes les parties du néphron et des cils primaires plus longs que les contrôles non transgéniques. Les analyses physiologiques supportent que les souris Pkd1TAG développent une insuffisance rénale et démontrent une augmentation du volume urinaire de même qu’une diminution de l’osmolalité, de la créatinine et des protéines urinaires. De plus, les souris Pkd1TAG développent des kystes hépatiques, des anomalies cardiaques associées à des dépôts de calcium et des anévrismes cérébraux. La sévérité du phénotype augmente avec l’expression de Pkd1 appuyant l’hypothèse d’un mécanisme de dosage. Nous avons aussi déterminé que l’expression du transgène Pkd1TAG complémente le phénotype létal-embryonnaire des souris Pkd1-/-. D’autre part, nous avons générés 4 lignées de souris Pkd1ΔCoiled-coil (2 et 15 copies du transgène) dont le nombre de copies corrèle avec le niveau d’expression du transgène. Ces souris Pkd1ΔCoiled-coil, contrairement aux Pkd1TAG de même âge, ne développent pas de kystes et possèdent des cils primaires de longueur normale. Afin d’évaluer le rôle du motif coiled-coil en absence de polycystine-1 endogène, nous avons croisé les souris Pkd1ΔCoiled-coil avec les souris Pkd1-/-. Contrairement aux souris Pkd1-/- qui meurent in-utéro, les souris Pkd1ΔCoiled-coil; Pkd1-/- survivent ~10 à 14 jours après la naissance. Elles démontrent des kystes rénaux et pancréatiques sévères, un retard de croissance et des anomalies pulmonaires. Tous les segments du néphron sont affectés. Mon projet démontre que la surexpression de Pkd1 est un mécanisme pathogénique de la PKRAD tant au niveau rénal qu’extrarénal. De plus, il démontre que le motif coiled-coil est un élément déterminant dans la kystogenèse/PKRAD in-vivo. / Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder affecting 1:500 people worldwide, independently from sex and origin. ADPKD is characterized by formation of large bilateral kidney cysts affecting all segments of the nephron and increasing progressively in size and number leading to end stage renal failure by mid-fifty. Moreover, this systemic disease includes several extrarenal symptoms such as intracranial aneurysms, valvular defects and cysts formation in the liver and the pancreas. PKD1 and PKD2 genes mutations are involved in 85 and 15 % of the clinical cases. PKD genes encode polycystin-1 (PC-1) and -2 (PC-2), which both form a complex at the cell and ciliary membrane of renal epithelial cells. PC-1 is a large transmembrane protein with a small intracellular tail including a coiled-coil motif implicated in PC-1/PC-2 interaction in-vitro. Interestingly, specific mutations affecting the coiled-coil motif cause ADPKD in humans. The pathogenetic mechanism of ADPKD is unknown. In mice, both ablation (Pkd1-/-) or overexpression (SBPkd1TAG) of Pkd1 cause ADPKD, suggesting a dosage model. Ciliary anomalies are also linked to polycystic kidney disease. Herein, we evaluated in-vivo the role of Pkd1 in the development of renal and extrarenal manifestations of ADPKD and more specifically, the role of the coiled-coil motif in cystogenesis. We generated two constructions, wildtype Pkd1 (Pkd1TAG) and coiled-coil deleted Pkd1 (Pkd1ΔCoiled-coil), by homologous recombination from the wildtype Pkd1-BAC comprising the whole Pkd1 murine sequence. Three Pkd1TAG mice lines have been generated by microinjection and show expression patterns correlating with the copy number of the transgene (2, 5 and 15 copy). All Pkd1TAG mice develop renal cysts affecting all nephron segments as in ADPKD and longer primary cilia compared to wildtype mice. Physiologic analysis supports renal failure by increased urinary output and decreased of urinary proteins, osmolality and creatinin levels. Pkd1TAG mice also show cysts in the liver, cardiac and valvular anomalies associated with calcium deposition and cerebral aneurysms. The severity of the phenotype increased with Pkd1 expression suggesting a dosage model. Importantly, the Pkd1TAG transgene rescue embryonic lethality of Pkd1-/- mice. Furthermore, we generated 4 lines of Pkd1ΔCoiled-coil mice of 2 and 15 copies of the transgene correlating also to the level of expression. Compared to age-matched Pkd1TAG, Pkd1ΔCoiled-coil mice develop no cysts and show normal cilia length. To gain more insights on the role of coiled-coil motif in absence of endogenous Pc-1, we mated Pkd1ΔCoiled-coil with Pkd1-/- mice. Compared to the lethal embryonic Pkd1-/- mice, Pkd1ΔCoiled-coil; Pkd1-/- live ~ 10 to 14 days. They show severe renal and pancreatic cysts as well as growth retardation and pulmonary defects. My study demonstrates that Pkd1 overexpression is a pathogenic mechanism to induce ADPKD renal and extrarenal phenotype. Moreover, this work shows that the coiled-coil motif of polycystin-1 is a critical determinant in ADPKD cystogenesis.

Bacterial cytoskeleton is an exciting and relatively new field of research. Recent findings have proven that microbes are well-organized and neatly structured organisms. In this study we have shown that intermediate filament-like proteins with a characteristic rod domain architecture of coiled coil segments separated by non-coiled coil linkers, are widely spread among bacteria. We identified and characterized an intermediate filament-like protein (named FilP after filamentous protein) in Streptomyces coelicolor. It shares the characteristic biochemical property of eukaryotic intermediate filaments of formation of spontaneous filaments in vitro without requiring any energy or co-factor. We have provided here a preliminary model of its assembly in vitro. FilP also forms in vivo filaments in S. coelicolor hyphae, which are strongest at the sub-apical location of growing vegetative hyphae. We have proposed that FilP cytoskeletal network provides rigidity to the hyphae, especially at the growing tips, by interacting with an essential coiled coil protein DivIVA and possibly other partner elements, yet to be found. S. coelicolor is a well-studied model organism with a complicated life cycle. It germinates from a spore and spreads by forming branched vegetative hyphae. Lack of nutrients in the environment initiates formation of aerial hyphae in the air, perpendicular to the vegetative ones. The aerial hyphae differentiate into spore chains and eventually grey-pigmented dispersed individual spores are released. The signals involved in sporulation including cell division and chromosome segregation are not clear yet. We characterized here a novel locus consisting of two genes: a small putative membrane protein with no defined function, named SmeA and a member of the SpoIIIE/FtsK family, called SffA. The expression of this locus appears to be dependent on whiA and whiG-whiH-whiI pathways. This finding is intriguing as it can provide insight to the relationship between two apparently unrelated pathways, both leading to the same function of septation and maturation during sporulation.

No description available.

Protein folding studies have provided important insights about the key role of non-covalent interactions in protein structure and conformational stability. Some of these interactions include salt bridges, cation-π, and anion-Ï€ interactions. Understanding these interactions is crucial to developing methods for predicting protein secondary, tertiary, quaternary structure from primary sequence and understanding protein-protein interactions and protein-ligand interactions. Several studies have described how the interaction between two amino acid side chains have a substantial effect on protein structure and conformational stability. This is under the assumption that the interaction between the two amino acids is independent of surrounding interactions. We are interested in understanding how salt bridges, cation-π, and anion-π interactions affect each other when they are in close proximity. Chapter 1 is a brief introduction on noncovalent interactions and noncovalent interaction cooperativity. Chapter 2 describes the progress we have made measuring the cooperativity between noncovalent interactions involving cations, anions and aromatic amino acids in a coiled-coil alpha helix model protein. Chapter 3 describes cooperativity between cation, anion, and nonaromatic hydrophobic amino acids in the context of a coiled-coil alpha helix. In chapter 4 we describe a strong anion-π interaction in a reverse turn that stabilizes a beta sheet model protein. In chapter 5 we measure the interaction between a cysteine linked maleimide and two lysines in a helix and show that it is a general strategy to stabilize helical structure.

Molecular structures of biomaterials have close relation to their functions. We are interested in how biological building blocks assemble into the structures of native biomaterials and the hierarchy of those structures. We tackled the problem mainly with X-ray diffraction experiments and developed a thorough analysis technique to assign the X-ray signals to protein secondary structures and chitin. Three different types of biomaterials were examined: vimentin fibres, squid pens, and human hair. In vimentin fibres, we found that the secondary protein structures play an important role in the strength of the fibres. In native squid pens, we found a self-similar, hierarchical structure from millimetres down to nanometres. In human hair, we compared the signals corresponding to keratin proteins, intermediate filaments, and lipids between different subjects, and found small deviations. The structures of these three biomaterials, which encompass different orders of length scales, were described both quantitatively and graphically. We hope that this work will eventually allow us to understand how and why nature builds biomaterials this way. / Thesis / Master of Science (MSc)